Skip to content

Author

Danilo Malandrino

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Early Introduction and Prolonged Full-Dose Anakinra Reduce Recurrence Risk After Discontinuation in Recurrent Pericarditis: An International Multicenter Cohort.

BACKGROUND Anakinra is effective in recurrent pericarditis, yet optimal treatment duration and strategies for safe drug discontinuation remain uncertain. Identifying predictors of sustained remission after discontinuation is important for clinical management. METHODS We retrospectively analyzed 185 consecutive adult...

Danilo Malandrino, Alessandra Bettiol, A. Andreis et al. · 0 citations
Review Open access Oct 2026

Anticoagulation in advanced renal failure: do factor XI/XIa inhibitors represent the long-awaited shift?

Advanced chronic kidney disease (CKD), particularly stages G4-G5 and dialysis-dependent kidney failure, is one of the most challenging settings for anticoagulant therapy because thrombotic and bleeding risks coexist and often increase in parallel. Conventional anticoagulants, including vitamin K antagonists, direct ora...

Domenico Prisco, Edoardo Biancalana, Danilo Malandrino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.